Mycoplasmas are the smallest free-living organisms and cause a number of economically 25 important diseases affecting humans, animals, insects and plants. Here, we demonstrate that 26 highly virulent Mycoplasma mycoides subspecies capri (Mmc) can be fully attenuated via 27 targeted deletion of non-essential genes encoding, among others, potential virulence traits.
2

ABSTRACT: 24
Mycoplasmas are the smallest free-living organisms and cause a number of economically 25 important diseases affecting humans, animals, insects and plants. Here, we demonstrate that 26 highly virulent Mycoplasma mycoides subspecies capri (Mmc) can be fully attenuated via 27 targeted deletion of non-essential genes encoding, among others, potential virulence traits.
28
Five genomic regions, representing approximately ten percent of the original Mmc genome, 29 were successively deleted using Saccharomyces cerevisiae as an engineering platform.
30
Specifically, a total of 68 genes out of the 432 genes verified to be individually nonessential 31 in the JCVI-Syn3.0 minimal cell, were excised from the genome. In vitro characterization 32 showed that this mutant was similar to its parental strain in terms of its doubling time, even 33 though ten percent of the genome content were removed. A novel in vivo challenge model in 34 goats revealed that the wild-type parental strain caused marked necrotizing inflammation at 35 the site of inoculation, septicemia and all animals reaching endpoint criteria within seven days 36 after experimental infection. This is in contrast to the mutant strain, which caused no clinical 37 signs nor pathomorphological lesions. These results highlight, for the first time, the rational 38 design, construction and complete attenuation of a Mycoplasma strain via synthetic genomics 39 tools. Trait addition using the yeast-based genome engineering platform and subsequent in 40 vitro or in vivo trials employing the Mycoplasma chassis will allow us to dissect the role of 41 individual candidate Mycoplasma virulence factors and lead the way for the development of 42 an attenuated designer vaccine.
43
IMPORTANCE 44
Members of the Mycoplasma mycoides cluster cause important animal plaques in Africa and 45 Asia, which impact animal welfare, provision of food and the life of thousands of small-scale 46 farmers. We applied synthetic biology tools to Mycoplasma mycoides in order to design and 47 create a fully attenuated Mycoplasma strain that was subsequently confirmed in vivo using a 48 novel caprine infection model. This is the first time that a Mycoplasma mutant developed by 49 applying synthetic biology tools has been tested in vivo to pin point candidate virulence traits.
50
The mutant strain is similar to "apathogenic E. coli K12" strains that boosted the research on 51 host-pathogen interactions for the genus Escherichia and other bacterial genera.
52
INTRODUCTION 53
Bacteria belonging to the genus Mycoplasma are wall-less bacteria that cause massive 54 economic losses in the livestock sector (chickens, ruminants and pigs) and are responsible for 55 human pneumonia and sexually transmitted diseases (STDs). Currently, there is an absence of 56 commercial vaccines against infections with the human pathogens Mycoplasma pneumoniae 57 and Mycoplasma genitalium (1). In contrast, many livestock vaccines are commercialized, 58 which rely either on adjuvanted killed bacteria or on attenuated strains obtained after 59 successive rounds of sub-culturing or chemical mutagenesis (2). Due to these empirical 60 approaches, the exact mechanism triggering the attenuation is unknown for many of the 61 previously developed live attenuated Mycoplasma vaccines. Strikingly, these vaccines are far 62 from being optimal since they often display short durations of immunity and limited efficacy 63 (3) (4) (5) . A better understanding of pathogenicity and the identification of virulence traits would 64 foster next generation vaccines.
65
For many years, the lack of genetic tools has limited our basic understanding of Mycoplasma 66 pathogenicity. Due to their regressive evolution by gene loss , mycoplasmas appear to lack 67 many of the common bacterial effectors and toxins used to interact with their hosts or to 68 escape the hosts' immune systems (6, 7). Lipoproteins have been proposed to be involved in 69 both aspects by using their cytoadherent properties and allowing antigenic variability through 70 phase or sequence variation (8). Other candidate virulence traits, such as the Mycoplasma Ig 71 binding protein-Mycoplasma Ig protease (MIB-MIP) system (9) and the hydrogen peroxide 72 production system (10) have been suggested, but not confirmed in vivo.
73
The availability of a genome engineering platform that allows directed and precise 74 mutagenesis for Mycoplasma mycoides is undoubtedly a new starting point towards better 75 understanding of host-pathogen interactions. In this work, we engineered a Mmc strain by 76 deleting approximately one tenth of the genome, including candidate virulence traits. The 77 5 resulting mutant retains almost wild-type like growth characteristics and was attenuated both 78 in vitro and in vivo. The construction of this fully attenuated and safe laboratory Mycoplasma 79 strain paves the way for research into host-pathogen interactions and is a good starting point 80 to revisit the actual role of suggested virulence determinants in Mycoplasma.
6
RESULTS 82
Generation of the mutant strain GM12::YCpMmyc1.1-Δ68
83
To demonstrate attenuation of Mmc by rational design, five genomic regions were targeted in 84 this study. The precise localizations in the Mmc GM12 genome are shown in Figure 1A . The 85 first two target deletion regions contained genes encoding the glycerol-dependent hydrogen 86 peroxide metabolic pathway and its suggested ABC transporter encoded by the gtsABCD 87 operon (11). This pathway has been suggested to be a main virulence mechanism for M. 88 mycoides (11), but in vivo confirmation is still missing and in M. gallisepticum the pathway 89 does not seem to be linked to virulence (12). Thus, the genes glpF, glpK and glpO 90 (MMCAP2_0217-0219; 2,984-bp region; D1) and the gts gene region that includes the gene 91 lppB (MMCAP2_0456-0459; 4,950-bp region; D2) were deleted in the Mmc genome by the 92 yeast-based engineering method (13). As previously mentioned, lipoproteins were another 93 target of interest since they likely trigger not only host-pathogen interactions but also, 94 overwhelming immune reactions that result in inflammation (14). The lipoproteins encoded in 95 the D3 (MMCAP2_0014-0016; 4,677-bp region; D3) as well as the D5 region (lppQ, 96 MMCAP2_0889-0904; 24,906-bp region, D5) were also excised employing again the yeast-97 based engineering method. Finally, we deleted a large genomic region that contained the 98 Mycoplasma-specific F1-likeX0 ATPase (15), the MIB-MIP system (9) that has been shown 99 in vitro to modulate the action of immunoglobulins through specific degradation, an 100 integrative and conjugative element (ICE) (16) and several genes encoding other lipoproteins.
101
The ICE was targeted in an effort to reduce mobile elements from the Mmc genome. In this 102 case, about 70 kbp (MMCAP2_0550-0591; 69,220-bp region; D4) were targeted and deleted 103 from the Mmc genome using the yeast-based engineering method in one stretch. After each 104 cycle of deletions, the modified Mmc genome was isolated from yeast cells and transplanted 105 back into M. capricolum subsp. capricolum (Mcc) recipient cells to confirm the viability of 7 each mutant Mmc strain. Overall, the final mutant strain, named Mmc GM12::YCpMmyc1.1-107 Δ68, was generated in five sequential deletion cycles ( Figure 1A) . The gene knock-outs were 108 verified by amplifying across each deleted region ( Figure S1 ). Genomic DNA from the 109 GM12::YCpMmyc1.1-Δ68 was isolated and analyzed by sequencing to confirm the deletions 110 (Figure1B) . The genome sequence of GM12::YCpMmyc1.1-Δ68 was deposited at the ENA 111 database under the accession number LS483503.
112
The mutant strain GM12::YCpMmyc1.1-Δ68 is viable and unaffected in its morphology 113 or growth in axenic medium
114
The colonies of Mmc GM12::YCpMmyc1.1-Δ68 were of similar size to those of 115 GM12::YCpMmyc1.1 and GM12. Cell morphology of the GM12, the isogenic parental strain 116 GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-Δ68 strains was evaluated using scanning 117 electron microscopy ( Figure 2A ). All strains tested were globular in shape and lacked any 118 special morphological features. The diameter of the microorganisms was in the range of 500 119 nm, as expected for a Mycoplasma cell. The mutant GM12::YCpMmyc1.1-Δ68 grew with a 120 doubling time somewhat similar to that of the parental strains GM12 and 121 GM12::YCpMmyc1.1 ( Figure 2B ). Together, these results strongly suggest that the deletion 122 of approximately 100 kbp of genomic content from the Mmc genome did not adversely affect 123 structural integrity or in vitro growth of the mutant GM12::YCpMmyc1.1-Δ68.
124
Inability of the mutant strain GM12::YCpMmyc1.1-Δ68 to produce hydrogen peroxide 125 in the presence of glycerol in vitro 126 This pathway was completely deleted in the construction of the mutant strain 127 GM12::YCpMmyc1.1-Δ68. Therefore to phenotypically confirm the deletion, we measured 128 and compared hydrogen peroxide production levels between the control GM12, 129 GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-Δ68 in vitro. In the presence of the glycerol 130 substrate, the mutant GM12::YCpMmyc1.1-Δ68 shows a significant decrease in hydrogen 131 8 peroxide production when compared to its parental strains ( Figure 2C ). Indeed, while GM12 132 and GM12::YCpMmyc1.1 produced >0.3µM of H 2 O 2 , the mutant strain produced very low 133 amounts of H 2 O 2 (0.01µM), at least 30-fold lower under these conditions.
134
Inability of the mutant strain GM12::YCpMmyc1.1-Δ68 to degrade immunoglobulin in 135 vitro 136 Another potential virulence trait encoded by mycoplasmas is the MIB-MIP system, which 137 may play a role in immune evasion by cleavage of immunoglobulins ( Figure 3A ) (9).
138
Incubation of caprine IgG with GM12, GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-Δ68 139 showed a clear difference in the strains' abilities to degrade IgG ( Figure 3B ). The two bands 140 at 25 kDa and 50kDa corresponds to the IgG light and heavy chains. The mutant strain 141 GM12::YCpMmyc1.1-Δ68 exhibited no degradation of IgG, as noted by the lack of the 44 142 kDa band ( Figure 3B , black asterisk). This band, clearly visible in the other two strains, is 143 indicative of proteolytic cleavage of the IgG heavy chain. Another pattern of degradation, 144 with a band at a size of about 30 kDa, is visible in the three strains. It was previously reported 145 that this IgG cleavage is not specific or directly linked to the MIB-MIP system (9).
146
The mutant strain GM12::YCpMmyc1.1-Δ68 is fully attenuated in vivo.
147
We next tested whether GM12::YCpMmyc1.1-Δ68 was able to cause disease in its native 148 host. Sixteen male outbred goats (Capra aegagrus hircus) were used in this animal infection 149 trial. The animals were separated into two groups of equal numbers. After the infection, no 150 immediate clinical signs of disease were observed. Two animals in the GM12::YCpMmyc1.1-
151
Δ68 group had to be removed from the experiment, because of acquired wounds unrelated to 152 the infectious agent. Animal euthanasia was planned 28 days post infection (dpi). However, 153 all eight animals inoculated with the GM12 strain developed severe clinical signs, with 154 pyrexia starting 2-3 dpi ( Figure 4B ). Their body temperature continued to increase, up to 41-155 41.5°C, during the following days. The animals stopped feeding, were apathic and showed 156 9 signs of pain. According to the endpoint criteria stated in the animal experiment protocol, 157 they had to be euthanized between 5-6 dpi ( Figure 4A , red line). In sharp contrast, animals 158 inoculated with the GM12::YCpMmyc1.1-Δ68 mutant strain did not develop any clinical 159 signs of disease and were all monitored until the end of the trial ( Figure 4A ). Their body 160 temperatures fluctuated between 38°C and 39°C, with a few isolated cases where animals 161 showed temperatures above 39°C but, never for more than 2 consecutive days ( Figure 4B ).
162
The animals appeared to remain healthy and gained weight during the experiment ( 
10
Mmc GM12 was re-isolated from the blood of all animals experimentally infected with the 181 wild-type parental strain. Bacteremia was characterized by 10 6 up to 10 9 CCU.ml -1 of blood, 182 as measured by serial dilutions (Table 1) . Blood samples collected from goats infected with 183 GM12::YCpMmyc1.1-∆68 did not reveal any bacteremia.
184
The MIB-MIP system in Mmc GM12 is functional in vivo 185
The MIB-MIP system was shown to be active in vitro, and to be present in large amounts at 186 the cell surface (17) 
196
DISCUSSION 197
The first aim of this work was to fully attenuate a highly pathogenic strain of 198 Mycoplasma mycoides following a rational deletion design. The second aim was to verify this 199 attenuation in vivo using the native host, since no rodent animal models for highly virulent M. 
225
It was paramount for us that the mutant strain GM12::YCpMmyc1.1-Δ68 maintains a 226 doubling time similar to its parental strain, since we wanted to create a 'K12-like' strain that 227 can be further used as a cellular platform to introduce antigens or stretches of DNA. It was 228 interesting for us to observe that, despite complete removal of the glycerol pathway, which 229 maybe important for cell metabolism, there was no significant impact on in vitro growth. It is 230 known that there is a trade-off between genome size and growth rate. The drastic deletions in 231 the genome of JCVI-syn3.0 strain led to a substantial increase in the generation time, from 232 ~60 min to ~180 min (24). Recently, we also have shown that the deletion of a gene encoding 233 an enzyme important for synthesis of carbohydrates can subsequently lead to an increase in 234 the generation time (25). However, in this work, we significantly reduced the genome of 235 GM12 by more than 100 kbp (i.e. 106,737 bp) without seeing any significant difference in the 236 growth rate of GM12::YCpMmyc1.1-∆68 in comparison to the wild-type strain. Still, this 237 reduction represents ~10% of the initial genome size confirming that, in addition to the size of 238 the deletions, the nature of the genes deleted is also very likely to influence the generation 239 time of mycoplasmas.
240
The main goal of this work was to construct a fully attenuated Mmc strain, that is safe to 
280
To conclude, we confirmed, in vitro and in vivo, our ability to design a fully attenuated strain 281 via the precise reduction of ~10 % of the Mmc genome. However, we cannot currently 282 pinpoint the weight of each deletion on the observed attenuation. The total clearance of the 283 pathogen and the absence of a compelling humoral immune response, even at the inoculation 284 point, is surprising and supports the total abolishment of pathogenicity. Now it is necessary to 285 test more defined mutants such as a glpOKF mutant strain to get clarity about its real role in 286 pathogenicity.
287
In addition, the design of next generation vaccines for, but not restricted to, Mycoplasma 288 diseases will benefit from this study since a chassis that is fully attenuated and able to 289 accommodate antigens for vaccine delivery that can be constructed based on our deletion 290 mutant is now within reach. To induce a proper immune response via such a chassis, we have 291 the option to add genes that appropriately stimulate an inflammatory immune response or 292 alternatively, we can construct different chassis that direct responses towards Th1 or Th2 (Table S1 ).
338
Transplantation
339
The modified GM12::YCpMmyc1.1 genomes (D1 to D5) were transplanted into Mycoplasma 340 capricolum subsp. capricolum (Mcc) recipient cells with polyethylene glycol and selected for 341 tetracycline resistance as described previously (13, 37) . The resulting mutant strains were 342 subjected to multiplex PCRs and pulsed-field gel electrophoresis as described elsewhere (38) 343 to confirm integrity of the genome.
344
Confirmation of the mutants using next generation sequencing and mapping assembly 345 Total DNA of the strains GM12, GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-∆68 was 346 isolated as described before (39). DNA was sheared using sonication and subjected to Overnight cultures of Mycoplasma strains were grown at 37°C in SP4 medium containing 378 streptomycin (GM12) or tetracycline (GM12::YCpMmyc1.1, GM12::YCpMmyc1.1-Δ68) for 379 about 16 hours. Doubling times of the Mycoplasma strains were then determined as described 380 elsewhere (24), except that time interval samples were collected and processed at 0, 1, 2, 3, 4, 381 5, 6, 7, 9, 12, 15, and 24 h. 
382
In vitro hydrogen peroxide assay
383
Overnight cultures of Mycoplasma strains were grown as described above. When the pH of 384 overnight cultures reached 6.0 -6.5, they were inoculated into fresh SP4 medium at 1:200 385 dilution and incubated at 37 °C for different time intervals of 0, 5, 7, and 24 h. At each time 386 interval, an aliquot of culture was taken for DNA extraction (24) and another aliquot was 387 taken to determine hydrogen peroxide levels.
388
To determine hydrogen peroxide levels, the aliquots were spun at 14,000 rpm for 10 minutes 389 at 4°C. The pellets were washed with 1 ml of cold PBS, pH 7.5 to remove traces of media, and stored at -80°C. Afterwards, we determined the CFU using two aliquots. Just before 440 infection we thawed the vials and adjusted the concentration of Mycoplasma to 10 9 CFU per 441 mL -1 using broth. All 16 goats were infected transtracheally by needle puncture 5-10 cm distal 442 to the larynx. Each animal received 1 mL of Mmc GM12 or GM12::YCpMmyc1.1-∆68 liquid 443 culture (10 9 colony forming units per animal), followed by 5 mL of phosphate buffered saline 444 (PBS) . The animals were allowed to move freely within the ABSL2 unit and had ad libitum 445 access to water. They were fed ad libitum with hay and received pellets each morning. 
